The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage

Szer Jeff; Weisdorf Daniel; Querol Sergio; Foeken Lydia; Madrigal Alejandro

首页> 外文期刊>Bone marrow transplantation >The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage

【24h】

The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage

机译：Covid-19对全球供体造血干细胞产品的影响：附带损伤

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Bone marrow transplantation》 |2020年第10期|共2页
作者
Szer Jeff; Weisdorf Daniel; Querol Sergio; Foeken Lydia; Madrigal Alejandro;
展开▼
作者单位

Peter MacCallum Canc Ctr Clin Haematol Melbourne Vic Australia;

Univ Minnesota Blood &

Marrow Transplant Program Minneapolis MN USA;

Catalan Blood &

Tissue Bank BST Freder Duran &

Jorda Ctr Barcelona Spain;

World Marrow Donor Assoc Schipholweg 57 NL-2316 ZL Leiden Netherlands;

Royal Free Hosp Anthony Nolan Res Inst London England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Donor-Derived CD19-Targeted T Cell Infusion Eliminates B Cell Acute Lymphoblastic Leukemia Minimal Residual Disease with No Response to Donor Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation [J] . Yifei Cheng, Kaiyan Liu, Shasha Wang, 工程（英文） . 2019,第001期
2. Donor-Derived CD19-Targeted T Cell Infusion Eliminates B Cell Acute Lymphoblastic Leukemia Minimal Residual Disease with No Response to Donor Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation [J] . Yifei Cheng, Yuhong Chen, Chenhua Yan, 工程（英文） . 2019,第001期
3. Chronic ocular GVHD： limbal and conjunctival stem cell allografts from the same hematopoietic stem cell donor [J] . Elias F Jarade, Hala El Rami, Youssef Abdelmassih, 国际眼科杂志：英文版 . 2018,第009期
4. Infusions of recipient-derived cytokine-induced killer cells of donor origin eradicated residual disease in a relapsed leukemia patient after allo-hematopoietic stem cell transplantation [J] . ZHONG Zhao-dong, LUO Yi, ZOU Ping, 中华医学杂志（英文版） . 2012,第009期
5. Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products. [J] . Hurley CK, Foeken L, Horowitz M, Bone marrow transplantation . 2010,第5期

机译：参与全球范围内造血干细胞供体和产品交换的注册管理机构的标准，法规和认证。
6. Phase II Study Evaluating the Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem and Progenitor Cells for Allogeneic Hematopoietic Cell Transplantation and Phenotypic Characterization of the Leukapheresis Product [J] . Rettig Michael P., Uy Geoffrey L., Bashey Asad, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：II期研究评估BL-8040为动员供体造血干和祖细胞进行同种异体造血细胞移植的安全性和功效，以及表型施产物的表型表征
7. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-fre [J] . Keil F, Prinz E, Moser K, Transplantation: Official Journal of the Transplantation Society . 2003,第1期

机译：非清髓异基因造血干细胞移植后供体来源长期培养起始细胞的快速建立，以及供体T细胞嵌合对稳定植入和进展频率的重大预后影响
8. DONOR-SPECIFIC (DSA) ANTI-DP ANTIBODIES ASSOCIATE WITH GRAFT FAILURE IN MATCHED UNRELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION [C] . Stefan O. Ciurea, Fleur Aung, Pedro Cano, Clinical Histocompatibility Workshop. . 2010

机译：特异性（DSA）抗DP抗体与匹配的无关供体造血干细胞移植中的接枝衰竭相关联
9. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
10. Clinical impacts of tumor cell contamination of hematopoietic stem cell products in metastatic breast cancer patients undergoing autologous peripheral blood stem cell transplantation: multicenter trial. [O] . M. J. Ahn, Y. H. Noh, Y. S. Lee, 2001

机译：造血干细胞产品的肿瘤细胞污染在接受自体外周血干细胞移植的转移性乳腺癌患者中的临床影响：多中心试验。
11. Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products [O] . C K Hurley, L Foeken, M Horowitz, 2010

机译：涉及全球造血干细胞供体和产品交换的登记处的标准，法规和认证
12. Alteration in Graft Versus Host Reactivity and in Hematopoietic Stem Cells of Spleen Cell Inocula from Donor Mice Pretreated with Pertussis Antigen. [R] . eikman, e. a. bowser, r. t. 1971

机译：用百日咳抗原预处理供体小鼠的脾细胞接种物中移植物抗宿主反应性和造血干细胞的变化。

The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage

著录项

相似文献

相关主题

期刊订阅